CLINICAL_TRIALS
withdrawal
· 2016-09-28
Clinical Trial Update: Study to Determine the Effect of Azasite on Corneal Surface Irregularity [Phase 2]
Summary
A Phase 2 study evaluating azithromycin ophthalmic solution (Azasite) for corneal surface irregularity associated with Meibomian Gland Dysfunction has been with…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Philadelphia Eye Associates | Conditions: Meibomian Gland Dysfunction | Phase 2 | Status: WITHDRAWN